Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trialWinette T.A. van der Graaf, Peter Hohenberger, Jean‐Yves Blay et al.|The Lancet|2012Cited by 2.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upPaolo G. Casali, Martin Robinson, Sebastian Bauer et al.|Annals of Oncology|2018Cited by 1.6k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trialIan Judson, Winette T.A. van der Graaf, Jaap Verweij et al.|The Lancet Oncology|2014Cited by 1.2k
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upPaolo G. Casali, Jean‐Yves Blay, Martin Robinson et al.|Annals of Oncology|2018Cited by 751
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upPaolo G. Casali, Ofer Merimsky, Stefan Bielack et al.|Annals of Oncology|2018Cited by 641